A Study on the Immune Response, Safety and the Occurrence of Respiratory Syncytial Virus (RSV)-Associated Respiratory Tract Illness After Administration of RSV OA Vaccine in Adults 60 Years and Older

GSK Investigational Site, Turku

GSK Investigational Site, Madrid

GSK Investigational Site, Tampere

GSK Investigational Site, Salamanca

GSK Investigational Site, Valladolid

GSK Investigational Site, Seinäjoki

GSK Investigational Site, Kokkola

GSK Investigational Site, Oulu

GSK Investigational Site, Shanghai

GSK Investigational Site, Shanghai

GSK Investigational Site, Shanghai

GSK Investigational Site, Shanghai

GSK Investigational Site, Shanghai

GSK Investigational Site, Shanghai

GSK Investigational Site, Shanghai

GSK Investigational Site, Shanghai

GSK Investigational Site, Espoo

GSK Investigational Site, Helsinki

GSK Investigational Site, Tokyo

GSK Investigational Site, Elblag

GSK Investigational Site, Katowice

GSK Investigational Site, Katowice

GSK Investigational Site, Krakow

GSK Investigational Site, Lodz

GSK Investigational Site, Lublin

GSK Investigational Site, Sochaczew

GSK Investigational Site, Warsaw

GSK Investigational Site, Wroclaw

GSK Investigational Site, Guri-si

GSK Investigational Site, Incheon

GSK Investigational Site, Seoul

GSK Investigational Site, Ávila

GSK Investigational Site, Barcelona

GSK Investigational Site, Burgos

GSK Investigational Site, Belfast

GSK Investigational Site, Blackpool

GSK Investigational Site, Bristol

GSK Investigational Site, Cambridgeshire

GSK Investigational Site, Eynsham

GSK Investigational Site, Hounslow

GSK Investigational Site, Witney